Molecular epidemiology tuberculosis in the Barents region of the Russian Federation

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The molecular epidemiology of micobacteria tuberculosis among new cases is described in four administrative territories of the Barents region of the Russian Federation in the paper. The using of two methods of the molecular biology: the spoligotyping and RFLP are established that the prevailing genotype is Beijing (47.1 %). The given genotype possesses the highest level of clasters among all genotypes that testify to its active transfer. High fitness of the W-Beijing МВТ explains so wide circulation of the present genotype.

About the authors

A. O. Maryandyshev

Northern State Medical University

Author for correspondence.
Email: medaj@eco-vector.com

член-корреспондент РАМН

Russian Federation, Arkhangelsk, 163000

O. S. Toungoussova

Northern State Medical University

Email: medaj@eco-vector.com
Russian Federation, Arkhangelsk, 163000

A. A. Baranov

Northern State Medical University

Email: medaj@eco-vector.com
Russian Federation, Arkhangelsk, 163000

References

  1. Андреевская С. Н., Черноусова Л. Н., Смирнова Т. Г., Ларионова Е. Е., Кузьмин А. В. Трансмиссия штаммов микобактерий туберкулеза, обусловленная миграционными процессами в Российской Федерации (на примере миграции населения из Кавказского региона в Москву и Московскую область) // Проблемы туберкулеза и болезней легких. 2006. № 1. С. 29-35.
  2. Балабанова Я. М., Николаевский В. В., Радди М. и др. Преобладание штаммов Mycobacterium tuberculosis семейства Beijing и факторы риска их трансмиссии в Самарской области // Проблемы туберкулеза и болезней легких. 2006. № 2. С. 31-37.
  3. Матракшин А. Г., Месько Е. М., Белякова Н. К. идр. Генотипическая характеристика штаммов Mycobacterium tuberculosis из Республики Тыва // Проблемы туберкулеза и болезней легких. 2004. № 3. С. 37-40.
  4. Медведева Т. В, Огарков О. Б., Некипелов и др. MIRU-VNTR-генотипирование штаммов Mycobacterium tuberculosis в Восточной Сибири: семейство Beijing против Kilimanjaro // Молекулярная генетика, микробиология и вирусология. № 4. 2004. С. 33-38.
  5. Нарвская О. В., Мокроусов И. В., Лимещенко Е. В. и др. Характеристика циркулирующих на Северо-Западе России штаммов Mycobacterium tuberculosis с использованием сполиготипирования // Пробл. туб. 2002. № 4. С. 44-47.
  6. Abebe F., Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette - Guerin (BCG) vaccines: is there a link? // Clin. Exp. Immunol. 2006. Sep. Vol. 145. № 3. P. 389-397.
  7. Beijing/W genotype Mycobacterium tuberculosis and drug resistance // Emerg. Infect. Dis. 2006. May. Vol. 12. № 5. P. 736-743.
  8. Billington O. J., McHugh T. D., Gillespie S. H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis // Antimicrobial. Agents. Chemother. 1999. Vol. 43. P. 1866-1869.
  9. Brudey K., Driscoll J. R., Rigouts L. et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology // BMC Microbiol. 2006. Vol. 6. P. 23.
  10. Cohen T., Sommers B., Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis // Lancet Infect. Dis. 2003. Vol. 3. P. 13-21.
  11. Cole S.T., Brosch R., Parkhill J. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence // Nature. 1998. Jun 11. Vol. 393 (6685). P. 537-544.
  12. de Boer A. S., Borgdorff M. W., de Haas P. E. et al. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates // J. Infect. Dis. 1999. Oct. Vol. 180 (4). P. 1238-1244.
  13. Edlin B. R., Tokars L., Grieco M. H. et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome // N. Engl. J. Med. 1992. Jun 4. Vol. 326 (23). P 1514-1521.
  14. Gillespie S. H., Billington O. J., Breathnach A., McHugh T. D. Multiple drug-resistant Mycobacterium tuberculosis: evidence for changing fitness following passage through human hosts // Microb. Drug. Resist. 2002. Vol. 8. P. 273-279.
  15. Gillespie S. H. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective // Antimicrobial. Agents. Chemother. 2002. Vol. 46. P 267-274.
  16. Jonsen P. J., Simonsen G. S., Olsvik Ö. et al. Stability, persistence, and evolution of plasmid-encoded vanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice // Microb. Drug. Resist. 2002. Vol. 8. P. 161-170.
  17. Kremer K., Arnold C., Cataldi A. et al. Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains // J. Clin. Microbiol. 2005. Nov. Vol. 43 (11). P. 5628-5638.
  18. Li Z., Kelley C., Collins F., Rouse D. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs // J. Infect. Dis. 1998. Vol. 177. P. 1030-1035.
  19. Lopez B., Aguilar D., Orozco H. et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes // Clin. Exp. Immunol. 2003. Jul. Vol. 133(1). P.30-37.
  20. Marttila H. J., Soini H., Vyshnevskaya E. et al. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and Line probe assay // Scand. J. Infect. Dis. 1998. Vol. 30. P. 129-132.
  21. Morlock G. P., Plikaytis В. B., Crawford J. T. Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv // Antimicrob. Agents. Chemother. 2000. Vol. 44. P. 3298-3301.
  22. Pyle М. М. Relative numbers of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin // Proc. Staff. Meet. Mayo. Clin. 1947. Vol. 22. P. 465-473.
  23. Rossau R., Traore H., de Beenhouwer H. et al. Evaluation of the INNO-LiPA Rif. ТВ assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin // Antimicrob. Agents. Chemother. 1997. Vol. 41. P. 2093-2098.
  24. Spoligotyping kit manual // Isogen Life Science. 2005.
  25. Toungoussova O. S., Caugant D. A., Sandven P. et al. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype // FEMS Immunol. Med. Microbiol. 2004. Nov. 1. Vol. 42 (3). P. 281-290.
  26. Toungoussova O. S., Mariandyshev A., Bjune G. et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family // Clin. Infect. Dis. 2003. Sep. 1. Vol. 37 (5). P. 665-672.
  27. Toungoussova O. S., Sandven P., Mariandyshev A. O. et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia // J. Clin. Microbiol. 2002. Jun. Vol. 40 (6). P. 1930-1937.
  28. Van S. D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements // J. Intern. Med. 2001. Jan. Vol. 249 (1). P. 1-26.
  29. WHO. Global tuberculosis control: surveillance, planning, financing: WHO report 2006. Geneva: World Health Organization. 2006.
  30. WHO. The world health report 2004: changing history. Geneva: World Health Organization. 2004.
  31. WHO. Tuberculosis fact sheet № 104. 2006. Mar.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2007 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.